Exploring gene knockout strategies to identify potential drug targets using genome-scale metabolic models
Abstract Research on new cancer drugs is performed either through gene knockout studies or phenotypic screening of drugs in cancer cell-lines. Both of these approaches are costly and time-consuming. Computational framework, e.g., genome-scale metabolic models (GSMMs), could be a good alternative to...
Enregistré dans:
Auteurs principaux: | Abhijit Paul, Rajat Anand, Sonali Porey Karmakar, Surender Rawat, Nandadulal Bairagi, Samrat Chatterjee |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5cc3d92f081c43a59c89d39d060694cf |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response
par: Karol Szlachta, et autres
Publié: (2018) -
Bayesian genome scale modelling identifies thermal determinants of yeast metabolism
par: Gang Li, et autres
Publié: (2021) -
ReacKnock: identifying reaction deletion strategies for microbial strain optimization based on genome-scale metabolic network.
par: Zixiang Xu, et autres
Publié: (2013) -
Genome-scale CRISPR-Cas9 knockout screening in hepatocellular carcinoma with lenvatinib resistance
par: Yonggang Lu, et autres
Publié: (2021) -
Large Scale Metabolic Profiling identifies Novel Steroids linked to Rheumatoid Arthritis
par: Noha A. Yousri, et autres
Publié: (2017)